Licensing agreements are sometimes done prior to results coming out that provide funding for trials, but have up front payments and multiple milestone payments and conditions. They provide a cheaper option for big pharma to bring products to market while providing small companies with a pathway to commercialisation.
That's just how it is.
Ann: Trading Halt, page-18
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)